期刊文献+

艰难拟梭菌感染的实验室诊断及治疗进展 被引量:2

Advance of laboratory diagnosis and therapy of Clostridioides difficile infection
原文传递
导出
摘要 艰难拟梭菌(Clostridioides difficile,CD)是医院内感染性腹泻和抗生素相关性腹泻的主要病原菌,抗生素、高龄、接受侵入性操作以及免疫抑制剂和化疗药物的使用均可导致产毒的CD过度繁殖,引起艰难拟梭菌感染(Clostridioides difficile infection,CDI)。近年来,CDI的发病率和严重程度在全球范围内不断上升,且在多地出现高产毒株的暴发流行,给临床诊断和治疗带来严峻的考验,受到医疗界的广泛关注。CD的主要致病因子是毒素A和毒素B,因此毒素检测在CDI的实验室诊断中起着关键性的作用。鉴于CD毒素培养及分离鉴定较为困难,目前尚无一种检测方法能完美涵盖CDI的实验室诊断。因此本文将就CD的实验室检测方法、诊断及治疗的研究进展进行综述。 Clostridioides difficile is a leading pathogen of infectious diarrhea and antibiotic-associated diarrhea in hospitals.Antibiotics,advanced age,invasive procedures,and the use of immunosuppressive and chemotherapeutic drugs can all leads to excessive reproduction of toxin-producing CDs and cause C.difficile infection(CDI).In recent years,the incidence and severity of CDI have been increasing worldwide,and the outbreaks of high-virulent C.difficile strains have appeared in many places,which brought severe challenges to clinical diagnosis and treatment,and has received widespread attention from the medical community.The main pathogenic factors of C.difficile are toxin A and toxin B,therefore the detection of toxin is the most crucial part in the laboratory diagnosis of CDI.In view of the difficulty in culture and isolation and identification of C.difficile toxins,there is currently no single detection method that can perfectly diagnose CDI.Therefore,this article will review the research progress of laboratory detection methods,diagnosis and treatment of CDI.
作者 罗莹 张文 国承杰 肖盟 张延海 张昕 孙洪珍 LUO Ying;ZHANG Wen;GUO Cheng-jie;XIAO Meng;ZHANG Yan-hai;ZHANG Xin;SUN Hong-zhen(Zibo Central Hospital,Zibo,Shandong 255036,China;不详)
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2020年第15期2390-2395,共6页 Chinese Journal of Nosocomiology
基金 国家自然科学基金青年科学基金资助项目(81501807)。
关键词 艰难拟梭菌 致病机制 诊断试验 治疗 Clostridioides difficile Pathogenic mechanism Diagnostic Tests Therapy
  • 相关文献

参考文献1

二级参考文献6

  • 1Bartlett JG.Clinical practice.Antibiotic-associated diarrhea[J].N Engl J Med,2002,346(5):334-339.
  • 2McDonald EG,Milligan J,Frenette C,et al.Continuous proton pump inhibitor therapy and the associated risk of recurrent Clostridium difficile infection[J].JAMA Intern Med,2015.
  • 3Zilberberg MD,Reske K,Olsen M,et al.Risk factors for recurrent Clostridium difficile infection(CDI)hospitalization among hospitalized patients with an initial CDI episode:a retrospective cohort study[J].BMC Infect Dis,2014(14):306.
  • 4Bauer MP,Notermans DW,van Benthem BH,et al.Clostridium difficile infection in Europe:a hospital-based survey[J].Lancet,2011,377(9759):63-73.
  • 5Madan R,Jr WA.Immune responses to Clostridium difficile infection[J].Trends Mol Med,2012,18(11):658-666.
  • 6Britton RA,Young VB.Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance[J].Trends Microbiol,2012,20(7):313-319.

共引文献5

同被引文献12

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部